Alector Inc
(STU:0Z2)
€
3.98
-0.02 (-0.5%)
Market Cap: 391.41 Mil
Enterprise Value: -93.80 Mil
PE Ratio: 0
PB Ratio: 2.37
GF Score: 62/100 - Q4 2023 Alector Inc Earnings Call TranscriptFeb 27, 2024€5.85 (+1.74%)Earnings
- Alector Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Alector Inc Earnings Call TranscriptAug 03, 2023€6 (-1.64%)Earnings
- Alector Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- H.C. Wainwright with Alector TranscriptMay 24, 2023
- Alector Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Alector Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Alector Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Alector Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Alector Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Alector Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Alector Inc to Present New AL001 Data- Conference Call TranscriptMar 15, 2022
- Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVROBIO Inc and Annexon Inc in the Orphan CNS Panel at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Alector Inc to Present to Discuss Data Presented at 2021 Clinical Trials on Alzheimer's Disease Meeting TranscriptNov 12, 2021
- Alector Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Alector Inc at Citi BioPharma Conference (Virtual)- Panel: What's Next for Neurodegenerative Diseases TranscriptSep 08, 2021
- Alector Inc to Review the AL001 Phase 2 Results- Conference Call TranscriptJul 29, 2021
- Alector Inc to Discuss Collaboration with GlaxoSmithKline PLC for AL001 & AL101 Call TranscriptJul 02, 2021
- Alector Inc at Bank of America NAPA Healthcare Conference TranscriptJun 14, 2021
- Alector Inc to Host Virtual Key Opinion Leader Event on Frontotemporal Dementia TranscriptJun 11, 2021
- Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Alector Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Alector Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Alector Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Alector Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Alector Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Alector Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Alector, Inc. - Special Call TranscriptDec 13, 2019
- Alector Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Alector Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
H.C. Wainwright with Alector Transcript
May 24, 2023 / 03:00PM GMT
Release Date Price:
€7
(-0.71%)
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Good morning. I welcome you all to today's fireside chat with Alector, a neuroscience company that aims to harness the power of neuroinflammation to combat neuroinflammation. Today, we have with us Alector's CEO, Arnon Rosenthal; and CFO, Marc Grasso. So.
Marc Grasso
Alector, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer
Hi, Ananda, pleasure to be here with you.
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Sorry, there is some background happening. Are we good now?
Marc Grasso
Alector, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer
I can hear you loud and clear.
Ananda Kumar Ghosh
H.C. Wainwright & Co, LLC, Research Division - Analyst
Okay. So let me just start begin with asking you -- Hi, (inaudible) there is some feedback, which I'm getting. Okay.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)